Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
Exome Asset Management
New YorkGrowth–Late Stage
Fosun RZ Capital
BeijingSeed–Growth
FountainVest Partners
Grand CaymanGrowth–Late Stage
GL Ventures
BeijingSeed–Growth
Greater Bay Area Homeland Development Fund
Hong KongSeed–Growth
Haier HOPE / HCH innovation platform
QingdaoPre-Seed–Growth
Imperial Capital Group Ltd
TorontoGrowth–Late Stage
Innovate Calgary
CalgaryPre-Seed–Growth
INVESTORO
Pre-Seed–Growth
IP Group
LondonSeed–Late Stage
Jinvest
VancouverSeed–Growth
LAFISE Investment Management
Growth–Late Stage
Lake Bleu Capital
Hong KongSeed–Growth
Lightrock
Series A–Growth
Northern Gritstone
ManchesterSeed–Growth
Oasis Capital Ghana
AccraGrowth
Onex Corporation
Englewood CliffsGrowth–Late Stage
Peloton Capital Management
Toronto, OntarioGrowth–Late Stage
Persistence Capital Partners
MontrealGrowth–Late Stage
Philips Ventures
AmsterdamSeed–Growth
Plug and Play China
ShanghaiPre-Seed–Growth
RecapHealth Ventures
VancouverSeed–Late Stage
RELX Ventures
LondonSeed–Growth
Roadmap Capital Inc.
TorontoSeed–Late Stage
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.